Robert D. Brook

Active 2001–2025

111
Papers
32,062
Citations
73
h-index
105
i10-index

Citations

Citations per year for Robert D. Brook1985: 1 citations1986: 4 citations1987: 1 citations1991: 1 citations1999: 1 citations2001: 1 citations2002: 6 citations2003: 16 citations2004: 32 citations2005: 55 citations2006: 75 citations2007: 60 citations2008: 90 citations2009: 128 citations2010: 122 citations2011: 146 citations2012: 164 citations2013: 199 citations2014: 202 citations2015: 205 citations2016: 300 citations2017: 292 citations2018: 360 citations2019: 857 citations2020: 1,048 citations2021: 963 citations2022: 743 citations2023: 596 citations2024: 821 citations2025: 332 citations2026: 20 citations1988–1990: no citations, so these years are not shown1992–1998: no citations, so these years are not shown2000: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,571 citing papers, 23.1% of this breakdownChina: 1,152 citing papers, 10.4% of this breakdownUnited Kingdom: 883 citing papers, 7.9% of this breakdownItaly: 517 citing papers, 4.7% of this breakdownGermany: 512 citing papers, 4.6% of this breakdownCanada: 508 citing papers, 4.6% of this breakdownNetherlands: 347 citing papers, 3.1% of this breakdownAustralia: 343 citing papers, 3.1% of this breakdownSpain: 319 citing papers, 2.9% of this breakdownFrance: 249 citing papers, 2.2% of this breakdownSweden: 225 citing papers, 2% of this breakdownSwitzerland: 213 citing papers, 1.9% of this breakdown
0%23.1%Other 29.5%

Fields

  • Medicine42.7%
  • Environmental Science36.8%
  • Biochemistry, Genetics and Molecular Biology6.7%
  • Health Professions5.3%
  • Neuroscience1.2%
  • Social Sciences1%
  • Other6.3%

Topics

  • Air Quality and Health Impacts13.4%
  • Climate Change and Health Impacts5.9%
  • Noise Effects and Management3.5%
  • Chronic Obstructive Pulmonary Disease (COPD) Research2.9%
  • Blood Pressure and Hypertension Studies2.7%
  • Lipoproteins and Cardiovascular Health2.5%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Particulate Matter Air Pollution and Cardiovascular Disease

    Authors: , , , , , , , , , , , , , , - Circulation 2010 cited by 6,444

  2. Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , , , , , , , , , - Hypertension 2018 cited by 1,074

  3. Air Pollution and Cardiovascular Disease

    Authors: , , - Journal of the American College of Cardiology 2018 cited by 1,252

  4. Variation inPCSK9andHMGCRand Risk of Cardiovascular Disease and Diabetes

    Authors: , , , , , , , , , , - New England Journal of Medicine 2016 cited by 784

  5. Environmental determinants of cardiovascular disease: lessons learned from air pollution

    Authors: , , , - Nature Reviews Cardiology 2020 cited by 767

  6. An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal

    Authors: , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2021 cited by 337

  7. Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

    Authors: , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 363

  8. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

    Authors: , - Journal of the American Society of Hypertension 2018 cited by 731

  9. Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial

    Authors: , , , , , , , , - The Lancet 2016 cited by 504

  10. Environmental stressors and cardio-metabolic disease: part II–mechanistic insights

    Authors: , , , , , , , , - European Heart Journal 2016 cited by 366

  11. Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both

    Authors: , , , , - Journal of the American College of Cardiology 2015 cited by 431

  12. Personal-Level Protective Actions Against Particulate Matter Air Pollution Exposure: A Scientific Statement From the American Heart Association

    Authors: , , , , , , , , , - Circulation 2020 cited by 246

  13. Expert position paper on air pollution and cardiovascular disease

    Authors: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2014 cited by 875

  14. Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk

    Authors: , , , , , , , , , , , , , , - JAMA 2017 cited by 328

  15. Environmental stressors and cardio-metabolic disease: part I–epidemiologic evidence supporting a role for noise and air pollution and effects of mitigation strategies

    Authors: , , , , , , , , - European Heart Journal 2016 cited by 292

  16. Air Pollution and Cardiovascular Disease

    Authors: , , , , , , , , , , - Circulation 2004 cited by 2,382

  17. Relations of Change in Plasma Levels of LDL‐C, Non‐HDL‐C and apoB With Risk Reduction From Statin Therapy: A Meta‐Analysis of Randomized Trials

    Authors: , , , , , , , , - Journal of the American Heart Association 2014 cited by 146

  18. Noise and Air Pollution as Risk Factors for Hypertension: Part I—Epidemiology

    Authors: , , , , , , , , , - Hypertension 2023 cited by 73

  19. Effect of Particulate Matter Air Pollution on Cardiovascular Oxidative Stress Pathways

    Authors: , , , - Antioxidants and Redox Signaling 2017 cited by 363

  20. Low-Sodium DASH Diet Improves Diastolic Function and Ventricular–Arterial Coupling in Hypertensive Heart Failure With Preserved Ejection Fraction

    Authors: , , , , , , , , - Circulation Heart Failure 2013 cited by 188

  21. GLP-1 Agonists and Blood Pressure: A Review of the Evidence

    Authors: , , , , - Current Hypertension Reports 2016 cited by 91

  22. Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice

    Authors: , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2023 cited by 76

  23. Noise and Air Pollution as Risk Factors for Hypertension: Part II—Pathophysiologic Insight

    Authors: , , , , , , , , , - Hypertension 2023 cited by 70

  24. Air Pollution and Cardiovascular Disease

    Authors: , , - Current Problems in Cardiology 2015 cited by 512